CD7 expression on CD34+ cells from chronic myeloid leukaemia in chronic phase

American Journal of Hematology

Volumn 61, Issue 3, 1999, Pages 178-186

  Martin Henao G A ^a   Quiroga, R ^a   Sureda, A ^b   Garcia J ^a  

^a HOSPITAL DURAN I REYNALS   (Spain)

^b HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

CD34; CD7; Chronic myeloid; Chronic phase; Leukemia

Indexed keywords

CD19 ANTIGEN; CD33 ANTIGEN; CD34 ANTIGEN; CD7 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYTOKINE; PHORBOL ESTER;

ANTIGEN EXPRESSION; ARTICLE; BONE MARROW CELL; CELL LINEAGE; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; HEMATOPOIESIS; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

ADULT; ANTIGENS, CD; ANTIGENS, CD2; ANTIGENS, CD34; ANTIGENS, CD7; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; B-LYMPHOCYTES; BLAST CRISIS; CELLS, CULTURED; CYTOKINES; FEMALE; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOMAGNETIC SEPARATION; LEUKEMIA, MYELOID, CHRONIC; LEUKEMIA, MYELOID, PHILADELPHIA-POSITIVE; MALE; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-KIT; REFERENCE VALUES; TETRADECANOYLPHORBOL ACETATE;

EID: 0344654771     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1096-8652(199907)61:3<178::aid-ajh4>3.3.co;2-%23     Document Type: Article

References (37)

1. Fialkow P, Jacobson R, Papayannopoulou T. Chronic myelocytic leukaemia: clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte/macrophage. Am J Med 1977;63:125-130.
2. Nogueira-Costa R, Spitzer G, Khorana S, Pham Q, Kantarjian HM, Manning JT, Ordonez NG, Dicke KA. T-cell involvement in benign phase chronic myelogenous leukemia. Leuk Research 1986;10:1433-1439.
3. Martin PJ, Najfeld V, Hansen JA, Penfold GK, Jacobson RJ. Fialkow PJ. Involvement of the B-lymphoid system in chronic myelogenous leukaemia. Nature (London) 1980;287:49-50.
4. Hughes TP, Goldman JM. Chronic myeloid Leukemia. In Hoffman R, Benz EJ, Shattil SJ, Furie B, Cohen HJ, Silberstein LE (eds) Hematology. Basic Principles and Practice, 2nd edition. New York: Churchill Livingtone.
5. Kantarjian HM, Keating MJ, Talpaz M, Walters RS, Smith TL, Cork A, McCredie KB, Freireich EJ. Chronic myelogenous leukemia in blast crisis. Analysis of 242 patients. Am J Med 1987;83:445-454.
6. Cervantes F, Villamor N, Esteve J, Montoto S, Rives S, Rozman C, Montserrat E. 'Lymphoid' blast crisis of chronic myeloid leukaemia is associated with distinct clinicohaematological features. Br J Haematol 1998;100:123-128.
7. Griffin JD, Todd RF, Ritz J, Nadler LM, Canellos GP, Rosenthal D, Gallivan M, Beveridge RP, Weinstein H, Karp D, Schlossman SF. Differentiation patterns in the blastic phase of chronic myeloid leukemia. Blood 1983;61:85-91.
8. Ch'ang HJ, Tien HF, Wang CH, Chuang SM, Chen YC, Shen MC, Lin DT. Comparison of clinical and biologic features between myeloid and lymphoid transformation of Philadelphia chromosome positive chronic myeloid leukemia. Cancer Genet Cytogenet 1993;71:87-93.
9. Urbano-Ispizua A, Cervantes F, Montserrat E, Rozman C. Immunophenotypic characteristics of blast crisis of chronic myeloid leukaemia: correlations with clinico-biological features and survival. Leukemia 1993;7:1349-1354.
10. Nair C, Chopra H, Shinde S, Barbhaya S, Kumar A, Dhond S, Yejamanam B, Sapre R, Chougule A, Advani S. Immunophenotype and ultrastructural studies in blast crisis of chronic myeloid leukemia. Leuk Lymph 1995;19:309-313.
11. Parreira L, Kearney L, Rassool F, Babapulle VB, Matutes E, Parreira A, Tavares de Castro J, Goldman JM, Catovsky D. Correlation between chromosomal abnormalities and blast phenotype in the blast crisis of Ph-positive CGL. Cancer Genet Cytogenet 1986;22:29-34.
12. Bettelheim P, Lutz D, Majdic O, Paietta E, Haas O, Linkesch W, Neumann E, Lechner K, Knapp W. Cell lineage heterogeneity in blast crisis of chronic myeloid leukaemia. Br J Haematol 1985;59:395-409.
13. Valiron O, Clemancey-Marcille G, Troesch A, Schweitzer A, Prenant M, Hollard D, Berthier R. Immunophenotype of blast cells in chronic myeloid leukemia. Leuk Res 1988;12:861-872.
14. Saikia T, Advani S, Dasgupta A, Ramakrishnan G, Nair C, Gladstone B, Kumar MS, Badrinath Y, Dhond S. Characterisation of blast cells during blastic phase of chronic myeloid leukaemia by immunophenotyping - experience in 60 patients. Leukemia Res 1988;12:499-506 1988.
15. Civin CI, Banquerigo ML, Strauss LC, Loken MR. Antigenic analysis of hematopoiesis. VI. Flow cytometric characterization of My-10-positive progenitor cells in normal human bone marrow. Exp Hematol 1987;15:10-17.
16. Terstappen LWMM, Safford M, Loken MR. Flow cytometric analysis of human bone marrow III. Neutrophil maturation. Leukemia 1990;4: 657-663.
17. Martín-Henao GA, Inglés-Esteve J, Cancelas JA, García J. Isolation of CD34+ hematopoietic progenitor cells in chronic myeloid leukemia by magnetic activated cell sorting (MACS). Bone Marrow Transplantation 1996;18:603-609.
18. Siena S, Bregni M, Brando B, Belli N, Ravagnani L, Gandola L, Stern AC, Lansdorp PM, Bonadonna G, Gianni AM. Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. Blood 1991;77:400-409.
19. Strobl H, Takimoto M, Majdic O, Hocker P, Knapp W. Antigenic analysis of human haemopoietic progenitor cells expressing the growth factor receptor c-kit. Br J Haematol 1992;82:287-294.
20. Tjonnfjord GE, Steen R, Veiby OP, Morkrid L, Egeland T. Haemopoietic progenitor cell differentiation: flow cytometric assessment in bone marrow and thymus. Br J Haematol 1995;91:1006-1016.
21. Pontvert-Delucq S, Breton-Gorius J, Schmitt C, Baillou C, Guichard J, Najman A, Lemoine FM. Characterization and functional analysis of adult human bone marrow cells subsets in relation to B-lymphoid development. Blood 1993;82:417-429.
22. McCulloch EA. Stem cells in normal and leukemic hemopoiesis. Blood 1983;62:1-13.
23. Greaves MF, Chan LC, Furley AJW, Watt SM, Molgaard HV. Lineage promiscuity in hemopoietic differentiation and leukemia. Blood 1986; 67:1-11.
24. Haynes BF, Martin ME, Kay HH, Kurtzberg J. Early events in human T cell ontogeny. Phenotypic characterization and immunohistologic localization of T cell precursors in early human fetal tissue. J Exp Med 1988;168:1061-1080.
25. Sutherland DR, Rudd CE, Graves MF. Isolation and characterization of human T lymphocyte-associated glycoprotein (gp40). J Immunol 1984;133:327-333.
26. Pittaluga S, Raffeld M, Lipford ZH, Cossman J. 3A1(CD7) expression precedes T gene rearrangements in precursor T (lymphoblastic) neoplasms. Blood 1986;68:134-139.
27. Kurtzberg J, Denning SM, Nycum LM, Singer KH, Haynes BF. Immature human thymocytes can driven to differentiate into nonlymphoid lineages by cytokines from the thymic epithelial cells. Proc Natl Acad Sci USA 1989;86:7575-7579.
28. Barcena A, Muench MO, Galy AHM, Cupp J, Roncarolo MG, Phillips JH, Spits H. Phenotypic and functional analysis of T-cell precursors in the human fetal liver and thymus: CD7 expression in the early stages of T-and myeloid-cell development. Blood 1993;82:3401-3414.
29. Chabannon C, Wood P, Torok-Storb B. Expression of CD7 on normal human myeloid progenitors. J Immunol 1992;49:2110-2113.
30. Bertho JM, Mossalayi MD, Dalloul AH, Mouterde G, Debre P. Isolation of an early T-cell precursor (CFU-TL) from human bone marrow. Blood 1990;175:1064-1068.
31. Tien HF, Chou CC, Hwa-Chiu W, Chang CH, Hsing CC. Putative normal counterparts of leukaemic cells from CD7-positive acute myeloid leukaemia can be demonstrated in human haemopoietic tissues. Br J Haematol 1996;94:501-506.
32. Eaves C, Udomsakdi C, Cashman J, Barnett M, Eaves A. The biology of normal and neoplastic stem cells in CML. Leukemia Lymphoma 1993;11(suppl 1):255-257.
33. Clarkson BD, Strife A, Wisiewski D, Lambek C, Caprino N. New understanding of the pathogenesis of CML: a prototype of early neoplasia. Leukemia 1997;11:1404-1428.
34. Andrews RG, Singer JW, Bernstein ID. Precursors of colony-forming cells in humans can be distinguished from colony-forming cells by expression of the CD33 and CD34 antigens and light scatter properties. J Exp Med 1989;169:1721-1731.
35. Traweek SH, Ben-Ezra J, Braziel RM, Winberg CD. The in vitro response of CD2-positive acute myelogenous leukemia to proliferation and differentiation inducing agents. Leukemia Reserch 1990;14:433-440.
36. Eaves CR, Eaves AC. Cell culture studies in CML. Bailliere' s Clinic Haematol 1979;1:931-961.
37. Galvani D, Cawley C. Mechanism of action of -interferon in chronic granulocytic leukaemia: evidence for preferential inhibition of late progenitors. Br J Haematol 1989;73:475-479.